Mind Medicine Valuation

Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. Mind Medicine last-minute Real Value cannot be determined due to lack of data. The latest price of Mind Medicine is $0.0. Our model forecasts the value of Mind Medicine from analyzing the firm fundamentals such as Shares Owned By Insiders of 0.49 %, current valuation of 999.44 M, and Return On Equity of -75.78 as well as examining its technical indicators and probability of bankruptcy. In general, most investors recommend locking in undervalued stocks and disposing overvalued stocks since, at some point, asset prices and their ongoing real values will merge together.

Mind Medicine Total Value Analysis

Mind Medicine is now forecasted to have takeover price of 999.44 M with market capitalization of 705.87 M, debt of 0, and cash on hands of 80.09 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Mind Medicine fundamentals before making investing decisions based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
999.44 M705.87 M080.09 M

Mind Medicine Asset Utilization

One of the ways to look at asset utilization of Mind is to check how much profit was generated for every dollar of assets it reports. Mind Medicine secures a negative usage of assets of -41.54 %, losing $0.42 for each dollar of assets held by the firm. Inadequate asset utilization conveys that the company is being less effective with each dollar of assets it secures. Strictly speaking, asset utilization of Mind Medicine shows how discouraging it operates for each dollar spent on its assets.

Mind Medicine Ownership Allocation

Mind Medicine maintains a total of 326.13 Million outstanding shares. Roughly 99.0 % of Mind Medicine outstanding shares are held by general public with 0.49 pct. owned by insiders and only 0.46 % by institutional investors. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Mind Medicine Profitability Analysis

Net Loss for the year was (35.34 M).
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Mind Medicine's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Mind Medicine and how it compares across the competition.

Mind Medicine Growth Indicators

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Mind Medicine does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Float Shares286.28M
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment.
Note that the Mind Medicine information on this page should be used as a complementary analysis to other Mind Medicine's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Other Consideration for investing in Mind OTC Stock

If you are still planning to invest in Mind Medicine check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Mind Medicine's history and understand the potential risks before investing.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Bonds Directory
Find actively traded corporate debentures issued by US companies